Show simple item record

dc.contributor.authorDávila Fajardo, R
dc.contributor.authorOldenburger, E
dc.contributor.authorRübe, C
dc.contributor.authorLópez-Yurda, M
dc.contributor.authorPritchard-Jones, K
dc.contributor.authorBergeron, C
dc.contributor.authorGraf, N
dc.contributor.authorvan Grotel, M
dc.contributor.authorvan Tinteren, H
dc.contributor.authorSaunders, Daniel
dc.contributor.authorvan den Heuvel-Eibrink, M
dc.contributor.authorJanssens, G
dc.contributor.authorOldenburger, F
dc.date.accessioned2018-06-27T19:53:50Z
dc.date.available2018-06-27T19:53:50Z
dc.date.issued2018-04-25
dc.identifier.citationEvaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: results from the SIOP-WT-2001 Registry. 2018, Pediatr Blood Canceren
dc.identifier.issn1545-5017
dc.identifier.pmid29693799
dc.identifier.doi10.1002/pbc.27085
dc.identifier.urihttp://hdl.handle.net/10541/621053
dc.description.abstractTo evaluate the value of radiotherapy boost omission in patients with intermediate-risk, stage III Wilms tumours (WT) with positive lymph nodes (LN).
dc.language.isoenen
dc.rightsArchived with thanks to Pediatric blood & canceren
dc.titleEvaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: results from the SIOP-WT-2001 Registry.en
dc.typeArticleen
dc.contributor.departmentDepartment of Radiation Oncology, University Medical Center Utrecht and Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlandsen
dc.identifier.journalPediatric Blood & Canceren
html.description.abstractTo evaluate the value of radiotherapy boost omission in patients with intermediate-risk, stage III Wilms tumours (WT) with positive lymph nodes (LN).


This item appears in the following Collection(s)

Show simple item record